INTRODUCTION: The term "post-COVID-19 syndrome" describes a range of symptoms persisting beyond the acute phase of the disease. These symptoms predominantly include fatigue, muscle pain, shortness of breath, and psychological issues. Research additionally suggests the possibility of long-term neurological and psychiatric impairment associated with COVID-19. METHODOLOGY: The study included patients who visited the post-COVID outpatient clinic between April 2020 and June 2022. The examination included the detailed history taking, including the COVID-19 course, posteroanterior chest X-ray and pulmonary function tests. Anxiety level was assessed using the Beck Anxiety Inventory (BAI). The relationship between anxiety, demographic data, and course of the disease, need for hospital admission during the acute phase, oxygen therapy, post-inflammatory changes on the chest X-ray and lung function parameters was investigated. RESULTS: This study included 1756 patients who experienced COVID-19 and visited a post-COVID outpatient clinic. The majority of individuals experienced a mild form of the infection. The results showed that younger age and female gender were associated with significantly higher anxiety scores. Inpatients had lower BAI values than those who were not hospitalized during acute phase. Patients with post-inflammatory changes on chest X-ray had surprisingly lower BAI values. Lower values of FEV1 (forced expiratory volume in 1 second), DLCO (diffusing capacity of the lungs for carbon monoxide), and KCO (carbon monoxide transfer coefficient) were associated with significantly higher BAI values. Female gender was associated with higher levels of anxiety. In contrast, higher FEV1 values reduced the risk of a pathological level of anxiety. CONCLUSION: In our study, the influence of age, gender, inpatient care during the acute phase of infection, the presence of post-inflammatory changes on the chest diagram and selected parameters of lung function (FEV1, DLCO, and KCO) were shown to be important factors in the assessment of anxiety symptoms in post-COVID patients.

Department of Psychiatry University Hospital Olomouc Olomouc Czech Republic

Department of Respiratory Medicine and Tuberculosis University Hospital Olomouc Olomouc Czech Republic

See more in PubMed

Zawilska JB, Kuczyńska K. Psychiatric and neurological complications of long COVID. J Psychiatr Res. 2022;156:349–360. PMID: 36326545; PMCID: PMC9582925. doi:10.1016/j.jpsychires.2022.10.045 PubMed DOI PMC

Venkatesan P. NICE guideline on long COVID. Lancet Respir Med. 2021;9(2):129. doi:10.1016/S2213-2600(21)00031-X PubMed DOI PMC

Xie Q, Liu XB, Xu YM, Zhong BL. Understanding the psychiatric symptoms of COVID-19: a meta-analysis of studies assessing psychiatric symptoms in Chinese patients with and survivors of COVID-19 and SARS by using the symptom checklist-90-revised. Transl Psychiatry. 2021;11(1):290. PMID: 34001863; PMCID: PMC8127471. doi:10.1038/s41398-021-01416-5 PubMed DOI PMC

Taquet M, Geddes JR, Husain M, Luciano S, Harrison PJ. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. 2021;8(5):416–427. doi:10.1016/S2215-0366(21)00084-5 PubMed DOI PMC

Zeng N, Zhao YM, Yan W, et al. A systematic review and meta-analysis of long term physical and mental sequelae of COVID-19 pandemic: call for research priority and action. Mol Psychiatry. 2023;28(1):423–433. doi:10.1038/s41380-022-01614-7 PubMed DOI PMC

Di Gennaro F, Belati A, Tulone O, et al. Incidence of long COVID-19 in people with previous SARS-Cov2 infection: a systematic review and meta-analysis of 120,970 patients. Intern Emerg Med. 2023;18(5):1573–1581. doi:10.1007/s11739-022-03164-w PubMed DOI PMC

Fernández-de-Las-Peñas C, Gómez-Mayordomo V, de-la-Llave-Rincón AI, et al. Anxiety, depression and poor sleep quality as long-term post-COVID sequelae in previously hospitalized patients: a multicenter study. J Infect. 2021;83(4):496–522. doi:10.1016/j.jinf.2021.06.022 PubMed DOI PMC

Taquet M, Dercon Q, Luciano S, Geddes JR, Husain M, Harrison PJ. Incidence, co-occurrence, and evolution of long-COVID features: a 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLoS Med. 2021;18(9):e1003773. doi:10.1371/journal.pmed.1003773 PubMed DOI PMC

Skala M, Svoboda M, Kopecky M, et al. Heterogeneity of post-COVID impairment: interim analysis of a prospective study from Czechia. Virol J. 2021;18(1):1–5. doi:10.1186/s12985-021-01546-8 PubMed DOI PMC

Fung M. COVID-19. In: Broaddus VC, Ernst JD, King TE, Lazarus SC, editors. Murray & Nadel’s Textbook of Respiratory Medicine, 7th. Philadelphia: Elsevier; 2022:620–634.

Tsampasian V, Elghazaly H, Chattopadhyay R, et al. Risk factors associated with Post− COVID-19 condition: a systematic review and meta-analysis. JAMA Intern Med. 2023;183(6):566. doi:10.1001/jamainternmed.2023.0750 PubMed DOI PMC

Sonnweber T, Sahanic S, Pizzini A, et al. Cardiopulmonary recovery after COVID-19: an observational prospective multicentre trial. Eur Respir J. 2021;57(4):2003481. doi:10.1183/13993003.03481-2020 PubMed DOI PMC

Thomas M, Price OJ, Hull JH. Pulmonary function and COVID-19. Curr. Opin. Physiol. 2021;21:29–35. doi:10.1016/j.cophys.2021.03.005 PubMed DOI PMC

Zhao Y, Yang C, An X, et al. Follow-up study on COVID-19 survivors one year after discharge from hospital. Int J Infect Dis. 2021;112:173–182. doi:10.1016/j.ijid.2021.09.017 PubMed DOI PMC

Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Eur Respir J. 1993;6(Suppl 16):5–40. doi:10.1183/09041950.005s1693 PubMed DOI

Stanojevic S, Graham BL, Cooper BG, et al. Official ERS technical standards: global lung function initiative reference values for the carbon monoxide transfer factor for Caucasians. Eur Respir J. 2017;50(3):1700010. doi:10.1183/13993003.00010-2017 PubMed DOI

Kamarádová D, Praško J, Látalová K, et al. VALIDIZACE ČESKE VERZE BECKOV A INVENTAŘE UZKO STI. Ceská a Slovenská Psychiatrie. 2016;112(4).

Mastrorosa I, Del Duca G, Pinnetti C, et al. What is the impact of post-COVID-19 syndrome on health-related quality of life and associated factors: a cross-sectional analysis. Health Qual Life Outcomes. 2023;21(1):28. PMID: 36949439; PMCID: PMC10031164. doi:10.1186/s12955-023-02107-z PubMed DOI PMC

Gramaglia C, Gattoni E, Gambaro E, et al. Anxiety, Stress and Depression in COVID-19 Survivors From an Italian Cohort of Hospitalized Patients: results From a 1-Year Follow-Up. Front Psychiatry. 2022;13:862651. PMID: 35782424; PMCID: PMC9247238. doi:10.3389/fpsyt.2022.862651 PubMed DOI PMC

Boček J, Končelíková D, Vaněk J, Látalová K, Genzor S, Mizera J. VLIV PRŮBĚHU ONEMOCNĚNÍ COVID-19 NA MÍRU ÚZKOSTI U PACIENTŮ S POST-COVID SYNDROMEM. Ceská a Slovenská Psychiatrie. 2023;119(2).

Carvalho-Schneider C, Laurent E, Lemaignen A, et al. Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clin Microbiol Infect. 2021;27(2):258–263. PMID: 33031948; PMCID: PMC7534895. doi:10.1016/j.cmi.2020.09.052 PubMed DOI PMC

Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese center for disease control and prevention. JAMA. 2020;323(13):1239–1242. doi:10.1001/jama.2020.2648 PubMed DOI

Badenoch JB, Rengasamy ER, Watson C, et al. Persistent neuropsychiatric symptoms after COVID-19: a systematic review and meta-analysis. Brain Comm. 2022;4(1):fcab297. doi:10.1093/braincomms/fcab297 PubMed DOI PMC

Liu D, Baumeister RF, Veilleux JC, et al. Risk factors associated with mental illness in hospital discharged patients infected with COVID-19 in Wuhan, China. Psychiatry Res. 2020;292:113297. doi:10.1016/j.psychres.2020.113297 PubMed DOI PMC

Mazza MG, De Lorenzo R, Conte C, et al. Anxiety and depression in COVID-19 survivors: role of inflammatory and clinical predictors. Brain Behav Immun. 2020;89:594–600. doi:10.1016/j.bbi.2020.07.037 PubMed DOI PMC

Sperling S, Fløe A, Leth S, et al. Fatigue is a major symptom at COVID-19 hospitalization follow-up. J Clin Med. 2022;11(9):2411. PMID: 35566536; PMCID: PMC9106038. doi:10.3390/jcm11092411 PubMed DOI PMC

D’Cruz RF, Waller MD, Perrin F, et al. Chest radiography is a poor predictor of respiratory symptoms and functional impairment in survivors of severe COVID-19 pneumonia. ERJ Open Research. 2021;7(1). PubMed PMC

Livermore N, Butler JE, Sharpe L, McBain RA, Gandevia SC, McKenzie DK. Panic attacks and perception of inspiratory resistive loads in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2008;178(1):7–12. PMID: 18436789. doi:10.1164/rccm.200711-1700OC PubMed DOI

Gudmundsson G, Gislason T, Janson C, et al. Depression, anxiety and health status after hospitalisation for COPD: a multicentre study in the Nordic countries. Respir Med. 2006;100(1):87–93. PMID: 15893921. doi:10.1016/j.rmed.2005.04.003 PubMed DOI

Eren F, Demir A, Ozkan B. Is there a relationship between anxiety and depression with respiratory functions in patients with relapsing-remitting multiple sclerosis? Mult Scler Relat Disord. 2021;52:103023. PMID: 34049218. doi:10.1016/j.msard.2021.103023 PubMed DOI

Sharp M, Brown T, Chen E, Rand CS, Moller DR, Eakin MN. Psychological burden associated with worse clinical outcomes in sarcoidosis. BMJ Open Resp Resear. 2019;6(1):e000467. doi:10.1136/bmjresp-2019-000467 PubMed DOI PMC

Lemhöfer C, Bahmer T, Baumbach P, et al. Variations and predictors of post-COVID syndrome severity in patients attending a post-COVID outpatient clinic. J Clin Med. 2023;12(12):4013. PMID: 37373706; PMCID: PMC10298907. doi:10.3390/jcm12124013 PubMed DOI PMC